West Pharmaceutical Services Inc. Q3 Profit Decreases, But Beats Estimates

(RTTNews) - West Pharmaceutical Services Inc. (WST) reported a profit for third quarter that decreased from the same period last year but beat the Street estimates.

The company's bottom line came in at $136.0 million, or $1.85 per share. This compares with $161.3 million, or $2.14 per share, in last year's third quarter.

Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings of $136.1 million or $1.85 per share for the period.

Analysts on average had expected the company to earn $1.50 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 0.1% to $746.9 million from $747.4 million last year.

West Pharmaceutical Services Inc. earnings at a glance (GAAP) :

-Earnings (Q3): $136.0 Mln. vs. $161.3 Mln. last year. -EPS (Q3): $1.85 vs. $2.14 last year. -Revenue (Q3): $746.9 Mln vs. $747.4 Mln last year.

-Guidance: Full year EPS guidance: $6.55 to $6.75 Full year revenue guidance: $2.875 - $2.905 Bln